Avasopasem
-
Malvern-Based Biopharmaceutical Company Seeks FDA Approval for Cancer Therapy Drug
Malvern-based biopharmaceutical company Galera Therapeutics is filing for FDA approval of a new drug. The treatment, avasopasem, helps radiotherapy-induced severe oral mucositis, or painful ulcers…
-
Malvern’s Galera Therapeutics in Line for $37.5 Million Payday
Malvern-based Galera Therapeutics recently triggered a $37.5 million payment by completing enrollment for a late-stage study of Avasopasem. John George reported on the new drug…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
